Albuquerque Journal

Using poop to cure gut infections

- BY ANAND KUMAR Anand Kumar works in the Biosecurit­y and Public Health group at LANL. He is an Entreprene­urial Fellow under a joint initiative of the University of California and Los Alamos that helps early-career scientists pursue commercial­izing their te

If all disease begins in the gut, as Hippocrate­s declared more than 2,000 years ago, then surely the cures for those diseases must be tied to the gut, as well. That’s the basic idea behind research at Los Alamos National Laboratory that aims to make fecal transplant­s a thing of the past.

The gut — a.k.a. the gastrointe­stinal tract that starts at the mouth and ends at the anus — contains trillions of bacterial cells. A majority are good bacteria that reside in the nearly 30 feet of the large and small intestines. These good bacteria are responsibl­e for a person’s overall health.

But sometimes a harmful bacterium called Clostridiu­m difficile (C. diff) infects the gut, with symptoms that range from diarrhea to inflammati­on of the colon. Doctors typically treat the infection with antibiotic­s, but spores from C. diff often linger in the gut and re-infect the patient.

If the infection occurs more than twice, doctors often recommend a fecal transplant: They transplant poop from a person with a healthy gut into the gut of the infected patient. Sounds crazy, but the idea is that the healthy bacteria in the transplant­ed poop will fight off the C. diff infection. The process works about 95 percent of the time.

Although fecal transplant­s are fairly routine, not all doctors can perform them and not all hospitals are equipped to handle them. Here in New Mexico, for example, only four physicians at the University of New Mexico Hospital can perform fecal transplant­s.

On top of that, finding a good poop donor is challengin­g — typically, only three out of 100 people meet the donation requiremen­ts. Even so, donor samples aren’t screened for all pathogens, so although the transplant might cure a C. diff infection, it might cause another type of infection. Or the transplant might carry a behavior or condition, such as diabetes or depression, from the donor to the recipient — that’s how powerful gut bacteria are.

But what if scientists could identify and isolate the bacteria in a fecal sample that inhibit C. diff and then put just those bacteria into a pill or drink? That’s exactly what researcher­s at Los Alamos are doing — pulling together bacteria into a super-powerful cocktail that washes out the infection. The work exploits the Laboratory’s extensive biological research efforts developed in support of its national security mission.

Working with a syringe in an anaerobic glove box, scientists extract healthy gut bacteria from a donated fecal sample. They randomly place two to five gut bacteria together with

C. diff pathogen in millions of microdropl­ets — essentiall­y microscopi­c bubbles where the gut bacteria and pathogen can interact — and then identify the microdropl­ets where C. diff growth is suppressed. The gut bacteria in those microdropl­ets are then identified through sequencing and are mixed together into a cocktail that can be taken orally.

Not only is the cocktail safer than a fecal transplant, but it’s a heck of a lot more comfortabl­e (no tubes through the nose or colon) and affordable (transplant­s, which costs thousands of dollars, typically aren’t covered by insurance).

Although the cocktail is not yet in clinical testing, the Los Alamos research team hopes that one day it will be available over the counter. Then, people can take it as a precaution against C. diff or to treat an existing infection. Another precaution is a healthy diet full of colorful vegetables and unprocesse­d foods — Hippocrate­s would surely agree.

 ?? COURTESY OF LANL ?? Anand Kumar works with a biosafety level 2 facility at Los Alamos studying Clostridiu­m difficile bacteria, a serious health threat worldwide. Kumar, an Entreprene­urial Fellow at Los Alamos National Laboratory, is a member of the lab’s Biosecurit­y and...
COURTESY OF LANL Anand Kumar works with a biosafety level 2 facility at Los Alamos studying Clostridiu­m difficile bacteria, a serious health threat worldwide. Kumar, an Entreprene­urial Fellow at Los Alamos National Laboratory, is a member of the lab’s Biosecurit­y and...
 ??  ?? Anand Kumar
Anand Kumar

Newspapers in English

Newspapers from United States